SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
EXCLUSIVE: Evercore ISI Breaks Down Valeant / Salix Deal By the Numbers
February 23, 2015
 · 
1 min read
Sanofi Rumored to Announce Job Cuts in U.S. Before Feb. 9
Biotech Bay
BioSpace Poll Correctly Predicted New Sanofi CEO, Even Naming Correct Candidate
February 23, 2015
 · 
2 min read
Lone Star Bio
Fertile Women Love Variety In Men, Shopping, University Of Texas At San Antonio Study
February 17, 2015
 · 
3 min read
Lone Star Bio
Sex Life Rebounds For Long-Term Married Couples After 50 Years, Baylor University Study Reveals
February 16, 2015
 · 
3 min read
Biotech Bay
Poll Finds Massive Support for French, Male CEO At Sanofi
February 16, 2015
 · 
1 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
Hedge Fund Manager Picks Acorda Therapeutics as His First Victim Against the Pharmaceutical Industry and Its “BS” Patents
February 11, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Whopping 75% of Respondents Polled Say Smaller Biotechs Will Lead Hiring Rush in 2015
February 10, 2015
 · 
1 min read
BIOCEO15 Gilead COO Says 6-Week Timeline for Hep C Course Unrealistic, Outlines NASH, Cancer Strategies
Biotech Bay
BIOCEO15: New Report On Biotech Venture Capital Over Last 10 Years Finds Heavy Focus on R&D
February 10, 2015
 · 
3 min read
Lone Star Bio
8 Signs Associated With Impending Death In Cancer Patients Identified, University of Texas MD Anderson Cancer Center Reveals
February 10, 2015
 · 
3 min read
Lone Star Bio
An End To The Medicine Dropper For Eye Injuries? ACS Nano Reveals
February 5, 2015
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens
February 18, 2026
 · 
4 min read
Press Releases
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
 · 
3 min read
Press Releases
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 18, 2026
 · 
10 min read
Press Releases
Medicenna Therapeutics Announces Participation in Upcoming Conferences
February 18, 2026
 · 
4 min read
Press Releases
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026
February 17, 2026
 · 
1 min read
Press Releases
Diakonos Oncology Announces Study to Continue after First DSMB Safety Review of DOC1021 in Phase 2 GBM Study
February 17, 2026
 · 
3 min read
Press Releases
Clinical Utility of bioAffinity Technologies’ CyPath® Lung Test Demonstrated in Real-World Case Study
February 17, 2026
 · 
5 min read
Press Releases
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
February 17, 2026
 · 
5 min read
Press Releases
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company’s Recently Initiated Strategic Transformation
February 17, 2026
 · 
7 min read
Press Releases
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
February 17, 2026
 · 
3 min read
Load More